Incuding cellular immune responses to human papilloma virus using peptide and nuleic acid compositions

Details for Australian Patent Application No. 2009225354 (hide)

Owner Pharmexa Inc

Inventors Sette, Alessandro; Chesnut, Robert; Grey, Howard M.; Sidney, John; Celis, Esteban; Southwood, Scott

Agent Callinan

Pub. Number AU-A-2009225354

Parent 2006200654

Filing date 15 October 2009

Wipo publication date 5 November 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

29 October 2009 Complete Application Filed

5 November 2009 Application Open to Public Inspection

  Published as AU-A-2009225354

5 November 2009 Complete Application Filed

22 April 2010 Alteration of Name

  The name of the applicant has been altered to Epimmune Inc. 2010

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225355-Interactive and collaborative financial customer experience application

2009225353-Medical valve with positive flow characteristics